...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: seems to be a lot of competing BP interest in new prostate cancer drugs
Reply New Message
Prev Message Back To Forum Threaded View Next Message

From Nightowl from IV

 

https://endpts.com/with-pfizer-in-hot-pursuit-jj-loses-a-critical-patent-fight-as-it-scrambles-for-a-new-prostate-cancer-drug-ok/

 

I wonder if any BP's are knocking on Zenith door right now......

one has to think some sort of deal is not too far away.... 

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply